Le Journal du Vapoteur is an organization that provides the latest information about electronic cigarettes to consumers.
With the upcoming TPD review in Europe, it is more important than ever to raise our voices and protect e-cigarettes from potential restrictions through collective efforts. Informed consumers are the best defenders of our e-cigarette rights, making the work of Journal Du Vapoteur essential. We welcome Journal Du Vapoteur to our community and are excited to collaborate in support of e-cigarettes," said Liza Katsiashvili, community manager for WVA.
Statement
This article is compiled from third-party information and is intended for industry professionals for the purpose of exchange and learning.
This article does not represent the views of 2FIRSTS, and the company cannot confirm the truth and accuracy of its contents. The translation of this article is only intended for industry research and communication.
Due to limitations in our translation skills, the translated article may not fully reflect the original wording. Please refer to the original article for accuracy.
2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau, Taiwan or foreign-related statements and positions.
The copyright of compiled information belongs to the original media and author. If infringement occurs, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
